Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERGO: Tadalafil in Cushing's Syndrome Cardiomyopathy
NCT02611258Phase 2Completed
- Start
- Jul 2016
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in Cushing's syndrome. Started Jul 2016; status: completed.
02
Drugs
tadalafil
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT02611258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02611258.